Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Laura Soldovieri"'
Autor:
Laura Soldovieri, Gianfranco Di Giuseppe, Gea Ciccarelli, Giuseppe Quero, Francesca Cinti, Michela Brunetti, Enrico C. Nista, Antonio Gasbarrini, Sergio Alfieri, Alfredo Pontecorvi, Andrea Giaccari, Teresa Mezza
Publikováno v:
Molecular Metabolism, Vol 74, Iss , Pp 101754- (2023)
Background: Over the last decades, various approaches have been explored to restore sufficient β-cell mass in diabetic patients. Stem cells are certainly an attractive source of new β-cells, but an alternative option is to induce the endogenous reg
Externí odkaz:
https://doaj.org/article/d43e32cf29044d3c8ac89abf182b502f
Autor:
Paola Concolino, Elisa De Paolis, Simona Moffa, Maria Elisabetta Onori, Laura Soldovieri, Claudio Ricciardi Tenore, Maria De Bonis, Claudio Rabacchi, Concetta Santonocito, Martina Rinelli, Sebastiano Calandra, Andrea Giaccari, Andrea Urbani, Angelo Minucci
Next Generation Sequencing (NGS), now widely used in the clinical setting, offers an efficient and comprehensive molecular approach for patients with Familial hypercholesterolemia (FH). Although the dominant form of disease is mostly due to low-densi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65949c439fc3ba87e624b98b3b52a98b
https://doi.org/10.20944/preprints202305.2038.v1
https://doi.org/10.20944/preprints202305.2038.v1
Autor:
Gianfranco Di Giuseppe, Gea Ciccarelli, Laura Soldovieri, Umberto Capece, Chiara M.A. Cefalo, Simona Moffa, Enrico C. Nista, Michela Brunetti, Francesca Cinti, Antonio Gasbarrini, Alfredo Pontecorvi, Andrea Giaccari, Teresa Mezza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd1a6ccf1828c1db3ff2936318ed29b
https://hdl.handle.net/10807/230593
https://hdl.handle.net/10807/230593
Teplizumab: il primo farmaco 'disease-modifying' approvato dall’FDA per il diabete mellito di tipo 1
Autor:
Laura Soldovieri, Teresa Mezza
Publikováno v:
L'Endocrinologo. 24:327-328